Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

CRSPCRSP
10 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in CRISPR THERAPEUTICS AG

FARALLON CAPITAL MANAGEMENT, L.L.C. previously held 0 shares of CRSP (CRISPR THERAPEUTICS AG), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$35.7M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$47.32
0
2024-Q2
New
530,000
-
$28.6M0.1%$54.01
48
2020-Q3
Exited
0
-100.0%
$00.0%$84.99
0
2020-Q2
Decreased
150,000
-57.1%
$11M0.1%$75.05
0
2020-Q1
Unchanged
350,000
0.0%
$14.8M0.1%$44.29
0
2019-Q4
Decreased
350,000
-37.5%
$21.3M0.1%$61.84
0
2019-Q3
Increased
560,367
+12.1%
$23M0.2%$42.36
38
2019-Q2
Decreased
500,000
-31.0%
$23.6M0.2%$47.10
0
2019-Q1
Decreased
725,000
-42.0%
$25.9M0.2%$35.72
0
2018-Q4
New
1.3M
-
$35.7M0.3%$26.75
48

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used